Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Retatrutide (LY3437943) is an investigational compound that has not been approved by the FDA as of April 2026
Both oforglipron (Foundayo) and the oral pill version of Wegovy are approved in the US, and already seeing millions of prescriptions, and the Wegovy pill is now available in UK pharmacies after approval in June and Europe after July approval by the European Commission
You will be sent an email with a medical history intake/consent form that will need to be filled out prior to meeting with our Provider
Son JW, Kim S (2020) Comprehensive review of current and upcoming anti-obesity drugs
US$ 27.36
US$ 21.73
US$ 24.33
US$ 28.00
US$ 29.47
